Published in PLoS Pathog on October 05, 2007
Antigenic and genetic characteristics of swine-origin 2009 A(H1N1) influenza viruses circulating in humans. Science (2009) 25.61
Emergence and pandemic potential of swine-origin H1N1 influenza virus. Nature (2009) 11.34
Matrix protein 2 of influenza A virus blocks autophagosome fusion with lysosomes. Cell Host Microbe (2009) 3.79
Influenza virus evolution, host adaptation, and pandemic formation. Cell Host Microbe (2010) 3.13
A complicated message: Identification of a novel PB1-related protein translated from influenza A virus segment 2 mRNA. J Virol (2009) 2.94
Single gene reassortants identify a critical role for PB1, HA, and NA in the high virulence of the 1918 pandemic influenza virus. Proc Natl Acad Sci U S A (2008) 2.72
Antigenic fingerprinting of H5N1 avian influenza using convalescent sera and monoclonal antibodies reveals potential vaccine and diagnostic targets. PLoS Med (2009) 2.47
Pathology, molecular biology, and pathogenesis of avian influenza A (H5N1) infection in humans. Am J Pathol (2008) 2.36
Cellular networks involved in the influenza virus life cycle. Cell Host Microbe (2010) 2.23
Virulence-associated substitution D222G in the hemagglutinin of 2009 pandemic influenza A(H1N1) virus affects receptor binding. J Virol (2010) 2.17
PB1-F2 expression by the 2009 pandemic H1N1 influenza virus has minimal impact on virulence in animal models. J Virol (2010) 2.01
The pathogenesis of influenza virus infections: the contributions of virus and host factors. Curr Opin Immunol (2011) 1.95
Virulence determinants of pandemic influenza viruses. J Clin Invest (2011) 1.87
Current and future antiviral therapy of severe seasonal and avian influenza. Antiviral Res (2008) 1.86
2009 H1N1 influenza. Mayo Clin Proc (2009) 1.76
PB1-F2 proteins from H5N1 and 20 century pandemic influenza viruses cause immunopathology. PLoS Pathog (2010) 1.75
H5N1 influenza viruses: outbreaks and biological properties. Cell Res (2009) 1.72
Variations in the hemagglutinin of the 2009 H1N1 pandemic virus: potential for strains with altered virulence phenotype? PLoS Pathog (2010) 1.70
Emergence of fatal avian influenza in New England harbor seals. MBio (2012) 1.70
Pathobiological features of a novel, highly pathogenic avian influenza A(H5N8) virus. Emerg Microbes Infect (2014) 1.65
The effects of influenza A virus PB1-F2 protein on polymerase activity are strain specific and do not impact pathogenesis. J Virol (2010) 1.63
Norovirus regulation of the innate immune response and apoptosis occurs via the product of the alternative open reading frame 4. PLoS Pathog (2011) 1.61
Understanding influenza transmission, immunity and pandemic threats. Influenza Other Respir Viruses (2009) 1.60
The influenza virus protein PB1-F2 inhibits the induction of type I interferon at the level of the MAVS adaptor protein. PLoS Pathog (2011) 1.60
Induction and evasion of type I interferon responses by influenza viruses. Virus Res (2011) 1.59
Naturally occurring swine influenza A virus PB1-F2 phenotypes that contribute to superinfection with Gram-positive respiratory pathogens. J Virol (2012) 1.57
A single-amino-acid substitution in a polymerase protein of an H5N1 influenza virus is associated with systemic infection and impaired T-cell activation in mice. J Virol (2009) 1.56
The special neuraminidase stalk-motif responsible for increased virulence and pathogenesis of H5N1 influenza A virus. PLoS One (2009) 1.55
Viral RNA polymerase complex promotes optimal growth of 1918 virus in the lower respiratory tract of ferrets. Proc Natl Acad Sci U S A (2008) 1.53
Novel genotypes of H9N2 influenza A viruses isolated from poultry in Pakistan containing NS genes similar to highly pathogenic H7N3 and H5N1 viruses. PLoS One (2009) 1.53
Role of sialic acid binding specificity of the 1918 influenza virus hemagglutinin protein in virulence and pathogenesis for mice. J Virol (2009) 1.53
Differential contribution of PB1-F2 to the virulence of highly pathogenic H5N1 influenza A virus in mammalian and avian species. PLoS Pathog (2011) 1.49
From where did the 2009 'swine-origin' influenza A virus (H1N1) emerge? Virol J (2009) 1.49
Genetic and antigenic characterization of H1 influenza viruses from United States swine from 2008. J Gen Virol (2010) 1.48
Phylogeography and evolutionary history of reassortant H9N2 viruses with potential human health implications. J Virol (2011) 1.48
Genomic signatures of influenza A pandemic (H1N1) 2009 virus. Emerg Infect Dis (2009) 1.48
Progress in identifying virulence determinants of the 1918 H1N1 and the Southeast Asian H5N1 influenza A viruses. Antiviral Res (2008) 1.47
A single N66S mutation in the PB1-F2 protein of influenza A virus increases virulence by inhibiting the early interferon response in vivo. J Virol (2010) 1.44
Pathogenicity of highly pathogenic avian influenza virus in mammals. Vaccine (2008) 1.42
Identification of novel influenza A virus proteins translated from PA mRNA. J Virol (2012) 1.42
Molecular characterization of highly pathogenic H5N1 avian influenza viruses isolated in Sweden in 2006. Virol J (2008) 1.39
A seven-segmented influenza A virus expressing the influenza C virus glycoprotein HEF. J Virol (2008) 1.37
NP, PB1, and PB2 viral genes contribute to altered replication of H5N1 avian influenza viruses in chickens. J Virol (2008) 1.34
Reconstruction of the 1918 influenza virus: unexpected rewards from the past. MBio (2012) 1.34
The contribution of animal models to the understanding of the host range and virulence of influenza A viruses. Microbes Infect (2011) 1.32
Avian influenza A H5N1 virus: a continuous threat to humans. Emerg Microbes Infect (2012) 1.30
The NS1 protein of the 1918 pandemic influenza virus blocks host interferon and lipid metabolism pathways. J Virol (2009) 1.29
Influenza virus protein PB1-F2 inhibits the induction of type I interferon by binding to MAVS and decreasing mitochondrial membrane potential. J Virol (2012) 1.29
Full factorial analysis of mammalian and avian influenza polymerase subunits suggests a role of an efficient polymerase for virus adaptation. PLoS One (2009) 1.22
PB2 and hemagglutinin mutations are major determinants of host range and virulence in mouse-adapted influenza A virus. J Virol (2010) 1.21
OpenFluDB, a database for human and animal influenza virus. Database (Oxford) (2010) 1.20
Influenza A virus infection kinetics: quantitative data and models. Wiley Interdiscip Rev Syst Biol Med (2010) 1.18
Adaptive mutations resulting in enhanced polymerase activity contribute to high virulence of influenza A virus in mice. J Virol (2009) 1.18
Impact of amino acid mutations in PB2, PB1-F2, and NS1 on the replication and pathogenicity of pandemic (H1N1) 2009 influenza viruses. J Virol (2011) 1.17
Pathogenicity of highly pathogenic avian H5N1 influenza A viruses isolated from humans between 2003 and 2008 in northern Vietnam. J Gen Virol (2010) 1.17
Virulence determinants of avian H5N1 influenza A virus in mammalian and avian hosts: role of the C-terminal ESEV motif in the viral NS1 protein. J Virol (2010) 1.16
Simple, sensitive, and swift sequencing of complete H5N1 avian influenza virus genomes. J Clin Microbiol (2008) 1.15
Influenza viruses: breaking all the rules. MBio (2013) 1.14
Genomic and protein structural maps of adaptive evolution of human influenza A virus to increased virulence in the mouse. PLoS One (2011) 1.13
Virulence and genetic compatibility of polymerase reassortant viruses derived from the pandemic (H1N1) 2009 influenza virus and circulating influenza A viruses. J Virol (2011) 1.13
Current knowledge on PB1-F2 of influenza A viruses. Med Microbiol Immunol (2010) 1.12
Transcriptomic analysis of host immune and cell death responses associated with the influenza A virus PB1-F2 protein. PLoS Pathog (2011) 1.12
Overlapping signals for translational regulation and packaging of influenza A virus segment 2. Nucleic Acids Res (2011) 1.09
A single-amino-acid substitution in the HA protein changes the replication and pathogenicity of the 2009 pandemic A (H1N1) influenza viruses in vitro and in vivo. Virol J (2010) 1.09
Immunopathogenic and antibacterial effects of H3N2 influenza A virus PB1-F2 map to amino acid residues 62, 75, 79, and 82. J Virol (2011) 1.09
Connecting the study of wild influenza with the potential for pandemic disease. Infect Genet Evol (2013) 1.08
Influenza H1N1 A/Solomon Island/3/06 virus receptor binding specificity correlates with virus pathogenicity, antigenicity, and immunogenicity in ferrets. J Virol (2010) 1.08
Highly pathogenic H5N1 avian influenza virus induces extracellular Ca2+ influx, leading to apoptosis in avian cells. J Virol (2010) 1.07
Host adaptation and transmission of influenza A viruses in mammals. Emerg Microbes Infect (2014) 1.06
Introduction into Nigeria of a distinct genotype of avian influenza virus (H5N1). Emerg Infect Dis (2009) 1.04
PB1-F2 influenza A virus protein adopts a beta-sheet conformation and forms amyloid fibers in membrane environments. J Biol Chem (2010) 1.04
Pathogenesis of the 1918 pandemic influenza virus. PLoS Pathog (2011) 1.03
Expanded cocirculation of stable subtypes, emerging lineages, and new sporadic reassortants of porcine influenza viruses in swine populations in Northwest Germany. J Virol (2013) 1.03
The role of viral, host, and secondary bacterial factors in influenza pathogenesis. Am J Pathol (2015) 1.02
Effect of 1918 PB1-F2 expression on influenza A virus infection kinetics. PLoS Comput Biol (2011) 1.02
Three amino acid changes in PB1-F2 of highly pathogenic H5N1 avian influenza virus affect pathogenicity in mallard ducks. Arch Virol (2010) 1.02
Insights on influenza pathogenesis from the grave. Virus Res (2011) 1.01
Avian influenza viruses infect primary human bronchial epithelial cells unconstrained by sialic acid α2,3 residues. PLoS One (2011) 1.01
Innate immune evasion strategies of influenza viruses. Future Microbiol (2010) 1.00
Mutations in polymerase genes enhanced the virulence of 2009 pandemic H1N1 influenza virus in mice. PLoS One (2012) 1.00
Innate immunity to influenza virus: implications for future therapy. Expert Rev Clin Immunol (2008) 0.99
Mortality and morbidity burden associated with A/H1N1pdm influenza virus. PLoS Curr (2009) 0.99
Animal models for influenza virus pathogenesis, transmission, and immunology. J Immunol Methods (2014) 0.98
In Silico Prediction and Experimental Confirmation of HA Residues Conferring Enhanced Human Receptor Specificity of H5N1 Influenza A Viruses. Sci Rep (2015) 0.97
A unique influenza A (H5N1) virus causing a focal poultry outbreak in 2007 in Manipur, India. Virol J (2009) 0.97
Human influenza is more effective than avian influenza at antiviral suppression in airway cells. Am J Respir Cell Mol Biol (2010) 0.96
The proapoptotic influenza A virus protein PB1-F2 forms a nonselective ion channel. PLoS One (2010) 0.96
A(H5N1) Virus Evolution in South East Asia. Viruses (2009) 0.96
A high diversity of Eurasian lineage low pathogenicity avian influenza A viruses circulate among wild birds sampled in Egypt. PLoS One (2013) 0.94
Innate immunity to H5N1 influenza viruses in humans. Viruses (2012) 0.94
The host interactome of influenza virus presents new potential targets for antiviral drugs. Rev Med Virol (2011) 0.94
Restored PB1-F2 in the 2009 pandemic H1N1 influenza virus has minimal effects in swine. J Virol (2012) 0.94
A comprehensive map of the influenza A virus replication cycle. BMC Syst Biol (2013) 0.93
Influence of respiratory syncytial virus strain differences on pathogenesis and immunity. Curr Top Microbiol Immunol (2013) 0.93
Highly pathogenic H5N1 influenza A virus strains provoke heterogeneous IFN-α/β responses that distinctively affect viral propagation in human cells. PLoS One (2013) 0.92
Epidemiological and Evolutionary Inference of the Transmission Network of the 2014 Highly Pathogenic Avian Influenza H5N2 Outbreak in British Columbia, Canada. Sci Rep (2016) 0.91
The PA-gene-mediated lethal dissemination and excessive innate immune response contribute to the high virulence of H5N1 avian influenza virus in mice. J Virol (2012) 0.91
The low-pH stability discovered in neuraminidase of 1918 pandemic influenza A virus enhances virus replication. PLoS One (2010) 0.91
Mortality associated with influenza and respiratory syncytial virus in the United States. JAMA (2003) 31.71
Characterization of the reconstructed 1918 Spanish influenza pandemic virus. Science (2005) 17.19
Fatal outcome of human influenza A (H5N1) is associated with high viral load and hypercytokinemia. Nat Med (2006) 14.21
Clinical features and rapid viral diagnosis of human disease associated with avian influenza A H5N1 virus. Lancet (1998) 12.89
Rescue of influenza A virus from recombinant DNA. J Virol (1999) 11.54
Avian-to-human transmission of the PB1 gene of influenza A viruses in the 1957 and 1968 pandemics. J Virol (1989) 10.63
Aberrant innate immune response in lethal infection of macaques with the 1918 influenza virus. Nature (2007) 10.40
Structure and receptor specificity of the hemagglutinin from an H5N1 influenza virus. Science (2006) 10.04
A novel influenza A virus mitochondrial protein that induces cell death. Nat Med (2001) 9.90
The impact of influenza epidemics on mortality: introducing a severity index. Am J Public Health (1997) 7.81
A mouse model for the evaluation of pathogenesis and immunity to influenza A (H5N1) viruses isolated from humans. J Virol (1999) 6.03
Virus-specific CD8+ T cells in primary and secondary influenza pneumonia. Immunity (1998) 5.98
Influenza A virus PB1-F2 protein contributes to viral pathogenesis in mice. J Virol (2006) 4.74
Genetic characterization of H3N2 influenza viruses isolated from pigs in North America, 1977-1999: evidence for wholly human and reassortant virus genotypes. Virus Res (2000) 4.65
The impact of influenza epidemics on hospitalizations. J Infect Dis (2000) 4.28
Role of host cytokine responses in the pathogenesis of avian H5N1 influenza viruses in mice. J Virol (2006) 4.00
Depletion of lymphocytes and diminished cytokine production in mice infected with a highly virulent influenza A (H5N1) virus isolated from humans. J Virol (2000) 3.88
Molecular correlates of influenza A H5N1 virus pathogenesis in mice. J Virol (2000) 3.74
Simultaneous detection of 15 human cytokines in a single sample of stimulated peripheral blood mononuclear cells. Clin Diagn Lab Immunol (2003) 3.70
Influenza virus PB1-F2 protein induces cell death through mitochondrial ANT3 and VDAC1. PLoS Pathog (2005) 3.44
The NS1 gene contributes to the virulence of H5N1 avian influenza viruses. J Virol (2006) 3.03
Distinct pathogenesis of hong kong-origin H5N1 viruses in mice compared to that of other highly pathogenic H5 avian influenza viruses. J Virol (2000) 2.84
The epidemiology and clinical impact of pandemic influenza. Vaccine (2003) 2.38
PB1-F2, an influenza A virus-encoded proapoptotic mitochondrial protein, creates variably sized pores in planar lipid membranes. J Virol (2004) 2.12
Mitochondrial targeting sequence of the influenza A virus PB1-F2 protein and its function in mitochondria. FEBS Lett (2004) 2.09
Prevalence of PB1-F2 of influenza A viruses. J Gen Virol (2007) 1.88
Recommended biocontainment features for research and diagnostic facilities where animal pathogens are used. First International Veterinary Biosafety Workshop. Rev Sci Tech (1995) 1.81
Recent H5N1 avian influenza A virus increases rapidly in virulence to mice after a single passage in mice. J Gen Virol (2006) 1.76
The chronicle of influenza epidemics. Hist Philos Life Sci (1991) 1.31
Molecular characterization of the hemagglutinin and neuraminidase genes of H5N1 influenza A viruses isolated from poultry in Vietnam from 2004 to 2005. J Vet Med Sci (2006) 1.23
Pathogenicity of H5N1 influenza A viruses isolated in Vietnam between late 2003 and 2005. J Vet Med Sci (2006) 1.01
Dissection of cytotoxic and helper T cell responses. Cell Mol Life Sci (2005) 0.89
Characterization of the reconstructed 1918 Spanish influenza pandemic virus. Science (2005) 17.19
Influenza virus transmission is dependent on relative humidity and temperature. PLoS Pathog (2007) 8.61
A two-amino acid change in the hemagglutinin of the 1918 influenza virus abolishes transmission. Science (2007) 8.38
Structure of the uncleaved human H1 hemagglutinin from the extinct 1918 influenza virus. Science (2004) 6.70
Genomic analysis of increased host immune and cell death responses induced by 1918 influenza virus. Nature (2006) 6.46
Glycan microarray analysis of the hemagglutinins from modern and pandemic influenza viruses reveals different receptor specificities. J Mol Biol (2005) 6.17
Transmission of influenza virus in a mammalian host is increased by PB2 amino acids 627K or 627E/701N. PLoS Pathog (2009) 6.09
Human host factors required for influenza virus replication. Nature (2010) 5.28
Influenza A virus PB1-F2 protein contributes to viral pathogenesis in mice. J Virol (2006) 4.74
The Ebola virus VP35 protein inhibits activation of interferon regulatory factor 3. J Virol (2003) 4.73
A single amino acid substitution in 1918 influenza virus hemagglutinin changes receptor binding specificity. J Virol (2005) 4.71
Combinatorial antibody libraries from survivors of the Turkish H5N1 avian influenza outbreak reveal virus neutralization strategies. Proc Natl Acad Sci U S A (2008) 4.67
The guinea pig as a transmission model for human influenza viruses. Proc Natl Acad Sci U S A (2006) 4.58
Newcastle disease virus (NDV)-based assay demonstrates interferon-antagonist activity for the NDV V protein and the Nipah virus V, W, and C proteins. J Virol (2003) 4.45
Cellular transcriptional profiling in influenza A virus-infected lung epithelial cells: the role of the nonstructural NS1 protein in the evasion of the host innate defense and its potential contribution to pandemic influenza. Proc Natl Acad Sci U S A (2002) 4.26
Attenuation of equine influenza viruses through truncations of the NS1 protein. J Virol (2005) 4.16
Influenza virus vaccine based on the conserved hemagglutinin stalk domain. MBio (2010) 4.15
Pathogenicity and immunogenicity of influenza viruses with genes from the 1918 pandemic virus. Proc Natl Acad Sci U S A (2004) 4.00
Broadly protective monoclonal antibodies against H3 influenza viruses following sequential immunization with different hemagglutinins. PLoS Pathog (2010) 3.89
Interferon antagonist proteins of influenza and vaccinia viruses are suppressors of RNA silencing. Proc Natl Acad Sci U S A (2004) 3.85
High temperature (30 degrees C) blocks aerosol but not contact transmission of influenza virus. J Virol (2008) 3.77
Seroevidence for H5N1 influenza infections in humans: meta-analysis. Science (2012) 3.74
Neutralizing antibodies derived from the B cells of 1918 influenza pandemic survivors. Nature (2008) 3.47
Influenza virus PB1-F2 protein induces cell death through mitochondrial ANT3 and VDAC1. PLoS Pathog (2005) 3.44
Vaccination with a synthetic peptide from the influenza virus hemagglutinin provides protection against distinct viral subtypes. Proc Natl Acad Sci U S A (2010) 3.24
Protection of mice against lethal challenge with 2009 H1N1 influenza A virus by 1918-like and classical swine H1N1 based vaccines. PLoS Pathog (2010) 3.08
Protective immunity and susceptibility to infectious diseases: lessons from the 1918 influenza pandemic. Nat Immunol (2007) 3.04
Hemagglutinin stalk antibodies elicited by the 2009 pandemic influenza virus as a mechanism for the extinction of seasonal H1N1 viruses. Proc Natl Acad Sci U S A (2012) 2.96
Severe acute respiratory syndrome coronavirus open reading frame (ORF) 3b, ORF 6, and nucleocapsid proteins function as interferon antagonists. J Virol (2006) 2.78
Single gene reassortants identify a critical role for PB1, HA, and NA in the high virulence of the 1918 pandemic influenza virus. Proc Natl Acad Sci U S A (2008) 2.72
Live attenuated influenza viruses containing NS1 truncations as vaccine candidates against H5N1 highly pathogenic avian influenza. J Virol (2008) 2.71
Specific residues of the influenza A virus hemagglutinin viral RNA are important for efficient packaging into budding virions. J Virol (2007) 2.62
Newcastle disease virus V protein is a determinant of host range restriction. J Virol (2003) 2.61
The biology of influenza viruses. Vaccine (2008) 2.58
Cross-neutralization of influenza A viruses mediated by a single antibody loop. Nature (2012) 2.44
Pause on avian flu transmission research. Science (2012) 2.24
Engineered viral vaccine constructs with dual specificity: avian influenza and Newcastle disease. Proc Natl Acad Sci U S A (2006) 2.23
Existing antivirals are effective against influenza viruses with genes from the 1918 pandemic virus. Proc Natl Acad Sci U S A (2002) 2.21
Severe acute respiratory syndrome coronavirus ORF6 antagonizes STAT1 function by sequestering nuclear import factors on the rough endoplasmic reticulum/Golgi membrane. J Virol (2007) 2.18
Indoleamine 2,3-dioxygenase is a critical resistance mechanism in antitumor T cell immunotherapy targeting CTLA-4. J Exp Med (2013) 2.13
Transmission of influenza virus via aerosols and fomites in the guinea pig model. J Infect Dis (2009) 2.12
Chimeric hemagglutinin influenza virus vaccine constructs elicit broadly protective stalk-specific antibodies. J Virol (2013) 2.09
Influenza viruses expressing chimeric hemagglutinins: globular head and stalk domains derived from different subtypes. J Virol (2012) 2.07
Highly conserved regions of influenza a virus polymerase gene segments are critical for efficient viral RNA packaging. J Virol (2007) 2.05
Influenza virus transmission: basic science and implications for the use of antiviral drugs during a pandemic. Infect Disord Drug Targets (2007) 2.04
PB1-F2 expression by the 2009 pandemic H1N1 influenza virus has minimal impact on virulence in animal models. J Virol (2010) 2.01
Nipah virus V and W proteins have a common STAT1-binding domain yet inhibit STAT1 activation from the cytoplasmic and nuclear compartments, respectively. J Virol (2004) 1.98
Cellular proteins in influenza virus particles. PLoS Pathog (2008) 1.96
Oseltamivir-resistant influenza A viruses are transmitted efficiently among guinea pigs by direct contact but not by aerosol. J Virol (2008) 1.95
Transmission of pandemic H1N1 influenza virus and impact of prior exposure to seasonal strains or interferon treatment. J Virol (2010) 1.92
A pan-H1 anti-hemagglutinin monoclonal antibody with potent broad-spectrum efficacy in vivo. J Virol (2012) 1.90
Toward a universal influenza virus vaccine: prospects and challenges. Annu Rev Med (2013) 1.84
The M segment of the 2009 new pandemic H1N1 influenza virus is critical for its high transmission efficiency in the guinea pig model. J Virol (2011) 1.82
Functional replacement of the carboxy-terminal two-thirds of the influenza A virus NS1 protein with short heterologous dimerization domains. J Virol (2002) 1.81
A carboxy-terminal trimerization domain stabilizes conformational epitopes on the stalk domain of soluble recombinant hemagglutinin substrates. PLoS One (2012) 1.81
Oseltamivir-resistant variants of the 2009 pandemic H1N1 influenza A virus are not attenuated in the guinea pig and ferret transmission models. J Virol (2010) 1.72
Trafficking of viral genomic RNA into and out of the nucleus: influenza, Thogoto and Borna disease viruses. Virus Res (2003) 1.70
Unraveling the mystery of swine influenza virus. Cell (2009) 1.70
Influenza virus hemagglutinin stalk-based antibodies and vaccines. Curr Opin Virol (2013) 1.69
Nuclear localization of the Nipah virus W protein allows for inhibition of both virus- and toll-like receptor 3-triggered signaling pathways. J Virol (2005) 1.69
Influenza B virus NS1-truncated mutants: live-attenuated vaccine approach. J Virol (2008) 1.64
Effects of influenza A virus NS1 protein on protein expression: the NS1 protein enhances translation and is not required for shutoff of host protein synthesis. J Virol (2002) 1.63
One influenza virus particle packages eight unique viral RNAs as shown by FISH analysis. Proc Natl Acad Sci U S A (2012) 1.61
The influenza virus protein PB1-F2 inhibits the induction of type I interferon at the level of the MAVS adaptor protein. PLoS Pathog (2011) 1.60
In vivo bioluminescent imaging of influenza a virus infection and characterization of novel cross-protective monoclonal antibodies. J Virol (2013) 1.59
Transmission of a 2009 pandemic influenza virus shows a sensitivity to temperature and humidity similar to that of an H3N2 seasonal strain. J Virol (2010) 1.56
Blocking interhost transmission of influenza virus by vaccination in the guinea pig model. J Virol (2009) 1.50
Hemagglutinin-pseudotyped green fluorescent protein-expressing influenza viruses for the detection of influenza virus neutralizing antibodies. J Virol (2009) 1.50
Neutralizing antibodies against previously encountered influenza virus strains increase over time: a longitudinal analysis. Sci Transl Med (2013) 1.49
Influenza A virus PB1-F2: a small protein with a big punch. Cell Host Microbe (2007) 1.49
H3N2 influenza virus infection induces broadly reactive hemagglutinin stalk antibodies in humans and mice. J Virol (2013) 1.48
A combination in-ovo vaccine for avian influenza virus and Newcastle disease virus. Vaccine (2007) 1.48
Influenza virus infection increases p53 activity: role of p53 in cell death and viral replication. J Virol (2005) 1.47
Protection from the 2009 H1N1 pandemic influenza by an antibody from combinatorial survivor-based libraries. PLoS Pathog (2010) 1.46
An unconventional NLS is critical for the nuclear import of the influenza A virus nucleoprotein and ribonucleoprotein. Traffic (2005) 1.44
A single N66S mutation in the PB1-F2 protein of influenza A virus increases virulence by inhibiting the early interferon response in vivo. J Virol (2010) 1.44
Broad-spectrum antiviral that interferes with de novo pyrimidine biosynthesis. Proc Natl Acad Sci U S A (2011) 1.42
1976 and 2009 H1N1 influenza virus vaccines boost anti-hemagglutinin stalk antibodies in humans. J Infect Dis (2012) 1.41
Hemagglutinin Stalk-Reactive Antibodies Are Boosted following Sequential Infection with Seasonal and Pandemic H1N1 Influenza Virus in Mice. J Virol (2012) 1.40
Influenza A(H7N9) virus gains neuraminidase inhibitor resistance without loss of in vivo virulence or transmissibility. Nat Commun (2013) 1.37
A seven-segmented influenza A virus expressing the influenza C virus glycoprotein HEF. J Virol (2008) 1.37
Budding capability of the influenza virus neuraminidase can be modulated by tetherin. J Virol (2011) 1.35
Genome-wide mutagenesis of influenza virus reveals unique plasticity of the hemagglutinin and NS1 proteins. Proc Natl Acad Sci U S A (2013) 1.34
Advances in universal influenza virus vaccine design and antibody mediated therapies based on conserved regions of the hemagglutinin. Curr Top Microbiol Immunol (2015) 1.32
Interaction of moloney murine leukemia virus capsid with Ubc9 and PIASy mediates SUMO-1 addition required early in infection. J Virol (2006) 1.30
Modulation of influenza virus replication by alteration of sodium ion transport and protein kinase C activity. Antiviral Res (2008) 1.30
Pandemic 2009 H1N1 vaccine protects against 1918 Spanish influenza virus. Nat Commun (2010) 1.29
Influenza virus protein PB1-F2 inhibits the induction of type I interferon by binding to MAVS and decreasing mitochondrial membrane potential. J Virol (2012) 1.29
Universal epitopes of influenza virus hemagglutinins? Nat Struct Mol Biol (2009) 1.29
Oncolytic Newcastle disease virus for cancer therapy: old challenges and new directions. Future Microbiol (2012) 1.28
Preexisting human antibodies neutralize recently emerged H7N9 influenza strains. J Clin Invest (2015) 1.27
Induction of cross-reactive antibodies to novel H7N9 influenza virus by recombinant Newcastle disease virus expressing a North American lineage H7 subtype hemagglutinin. J Virol (2013) 1.26
Assessment of influenza virus hemagglutinin stalk-based immunity in ferrets. J Virol (2014) 1.26
Rewiring the RNAs of influenza virus to prevent reassortment. Proc Natl Acad Sci U S A (2009) 1.25
Comment on "Large-scale sequence analysis of avian influenza isolates". Science (2006) 1.25